Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial - sprookjes - yvandenbroek - TriplyDB

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

http://www.wikidata.org/entity/Q29615226

about

Differentiated Evaluation of Extract-Specific Evidence on Cimicifuga racemosa's Efficacy and Safety for Climacteric Complaints The haunting of medical journals: how ghostwriting sold "HRT"Hormone therapy for preventing cardiovascular disease in post-menopausal women Hormone therapy for preventing cardiovascular disease in post-menopausal women Long term hormone therapy for perimenopausal and postmenopausal women Progestogens for hot flushes Non-hormonal interventions for hot flushes in women with a history of breast cancer Evidence-Based Medicine as a Tool for Undergraduate Probability and Statistics Education Pathogenesis of osteoporosis: concepts, conflicts, and prospects European guidance for the diagnosis and management of osteoporosis in postmenopausal women Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes Venous thromboembolic disease Bioidentical hormones for menopausal hormone therapy: variation on a theme Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist Calcium plus vitamin D supplementation and the risk of breast cancer Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Management of osteoporosis Pharmacokinetics of isoflavones, daidzein and genistein, after ingestion of soy beverage compared with soy extract capsules in postmenopausal Thai women Large mobile thrombus in non-atherosclerotic thoracic aorta as the source of peripheral arterial embolism.Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy.The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.Sex and Gender Differences in Central Nervous System-Related Disorders Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene Androgen receptor (AR) in cardiovascular diseases Calcium intake and bone mineral density: systematic review and meta-analysis Progestogens in menopausal hormone therapy Molecular cancer prevention: Current status and future directions A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship The treatment of climacteric symptoms Mitochondria as a therapeutic target in heart failure Results of observational studies: analysis of findings from the Nurses' Health Study Postmenopausal hormone therapy and cognition Denosumab for the treatment of osteoporosis Salpingectomy as a means to reduce ovarian cancer risk Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status An overview on the treatment of postmenopausal osteoporosis

P2860

Q21284761-FED0771A-4B5E-4EE6-A71C-E474C9CF4C62 Q21563448-C55FFFC5-259A-4982-8D2A-B5A095400E7D Q24187326-135C92B2-2C01-4AEE-A3FD-951E8F83DE37 Q24197712-70F000FC-A190-4F85-BA69-896F157A7C31 Q24201974-D285C271-77BB-4593-8B92-EB288B233B60 Q24235130-25A75F54-DAEA-4529-8BB9-75F9A9D1C36A Q24235391-DCF6782D-59D7-4BFE-A676-CFC4AE4B3EA1 Q24288834-E98A30C5-D519-4C94-B2F9-17375896A0A6 Q24536164-BA19E460-9693-41ED-A67A-F703FCDDBBAE Q24612411-A7003B58-C8BC-4CF3-9714-A862E9EF58DB Q24626206-03589AD2-B441-48C4-8FB7-0C7DA52CC1F8 Q24631121-B4143EA7-A418-42F9-B3EF-44A5280135DC Q24643351-2EC8BE54-FB27-499F-AB0A-907B819E8D27 Q24647700-5ADD4EE7-A39D-4FAC-BF01-9AB4BEEA6BC8 Q24647720-CE666995-B916-46AC-B208-4EFFC4301BF8 Q24647962-CBD6DCAC-F93B-4B02-8858-F5AE69931FAF Q24653880-E649D461-8F49-404B-92DF-11216E154509 Q24658107-98F6CAA4-CAE1-4956-B6E6-0097B24F1351 Q24658109-F31AC111-4CD9-4AE1-A165-3479964190B5 Q24795473-8E97264D-0E41-4A88-B5F9-198EA6B1CCA4 Q24805037-62FE8F26-5DED-4E84-8090-6918F3124EBA Q24812555-A8FB6A0B-11E9-4C5F-9328-4D8A8FB67936 Q24814779-5BBD68F3-67E9-4600-A047-CCC78B6C5FBB Q25257485-C654C794-A657-4602-96E1-62BC54C890DA Q26744569-42774D37-5C7F-4B4D-ABF8-3A75497E2241 Q26751149-729DD19B-2499-4010-9921-45F0A913BD02 Q26771962-B8237610-EA8C-4C3D-916E-B659997CFA4E Q26784337-8B3693E9-A333-476D-8AA2-D2A8B64E48CC Q26795567-E5336A56-64BA-4BF8-A846-120427A85292 Q26797207-F2978EA3-1CBF-4E92-BEA7-2A8400F44B0B Q26822460-D48A22FD-E83A-4BB2-9FD3-46198283CAC1 Q26865759-A30A6421-8150-4522-A9D5-87E8C177864C Q26992273-B5DB6037-85DE-4662-A433-7FB1244FF446 Q27005632-72F8877D-06AF-4D19-89E7-1C68641833EC Q27006022-24A14B7C-037D-4AB9-B2F5-2A96C9FD3C0E Q27008086-1CC1ED9A-E06C-49C6-963B-55F090F9239F Q27009275-FD0C0F64-45DD-4481-B14D-043A044BF8F2 Q27011949-D37BB5D8-5C78-4EB1-A9AC-A7BD01A94A3C Q27012792-5BABC1C0-8467-4C97-ACF3-88165C420ABF Q27013070-8DAE4AB2-DA28-418C-9F22-31A393D97891

P2860

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

http://www.wikidata.org/entity/Q29615226

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Effects of conjugated equine e ...... ve randomized controlled trial

@ast

Effects of conjugated equine e ...... ve randomized controlled trial

@en

type

label

Effects of conjugated equine e ...... ve randomized controlled trial

@ast

Effects of conjugated equine e ...... ve randomized controlled trial

@en

prefLabel

Effects of conjugated equine e ...... ve randomized controlled trial

@ast

Effects of conjugated equine e ...... ve randomized controlled trial

@en

P1433

Q29615226-25277E81-6F0B-4BDB-9370-2FEBC9EFC745

P1476

Q29615226-6D77D0B1-BEB2-42C2-950D-0F04BBD4837B

P2093

Q29615226-00C132CB-09B2-40DF-9271-1F484DC417E3

Q29615226-02E95649-7889-4B38-8FF9-D12CFC018186

Q29615226-060E6EBE-E99A-4FAF-AF09-379353E79E90

Q29615226-07FB06F7-691F-41F0-B2EC-41A5653D9CC4

Q29615226-1A0CFC04-1996-4260-AB79-F4A6CC98BD20

Q29615226-25001E28-5AF1-4FEB-8350-7953394BD2BC

Q29615226-2F0B300D-C052-4B20-BAC8-AFC5B5CE9706

Q29615226-338E8204-6FB0-4B4F-B5BF-9A4EB76C7DB8

Q29615226-41A56451-B13E-4C3A-87F4-34ED6CE82C6B

Q29615226-4383B4C1-68AE-4F3F-B159-6CEE6D6CA41A

P304

Q29615226-D16BB5FF-E1CF-421B-88C3-B100B8A7AAB0

P31

Q29615226-8842552F-0521-46B7-BD3F-B08E973EDAE4

P3181

Q29615226-D48835CD-FA3A-4B66-BCC2-85CA275511BD

P356

Q29615226-21C91692-82F9-4568-9B06-7B077FCFA4B4

Q29615226-BD8BE9DD-2F1D-47E2-8379-DACCBDD270F4

P407

Q29615226-C92E59A1-2CC6-42A0-A5E2-9F9659D08CB4

P433

Q29615226-60BC4E9A-661E-4237-8B60-827FB44186F1

P478

Q29615226-38D491E7-F726-4E83-9976-61883C201AEE

P50

Q29615226-69de3ab5-4e02-8f70-4add-b0cf42ec7355

Q29615226-6f344788-4518-6211-b798-1fdec07c2492

Q29615226-b23f1a65-4684-4b91-d41f-dc08eb547689

P577

Q29615226-B1B5D9FD-4540-4A08-8202-E960E9E329EC

P698

Q29615226-5ABAA97E-1032-46AE-8570-24CBD522C4FB

P921

Q29615226-5DCAA173-B92B-4DE6-B737-391A360ABEDF

Q29615226-BC9D6E04-B2A6-4C0B-B909-FEB4668BD892

P3181

P356

JAMA.291.14.1701

JAMA.291.14.1775

P1433

Journal of the American Medical Association

P1476

Effects of conjugated equine e ...... ve randomized controlled trial

@en

P2093

Anderson GL

http://www.w3.org/2001/XMLSchema#string

Assaf AR

http://www.w3.org/2001/XMLSchema#string

Bassford T

http://www.w3.org/2001/XMLSchema#string

Beresford SA

http://www.w3.org/2001/XMLSchema#string

Black H

http://www.w3.org/2001/XMLSchema#string

Bonds D

http://www.w3.org/2001/XMLSchema#string

Brunner R

http://www.w3.org/2001/XMLSchema#string

Brzyski R

http://www.w3.org/2001/XMLSchema#string

Caan B

http://www.w3.org/2001/XMLSchema#string

Chlebowski R

http://www.w3.org/2001/XMLSchema#string

P304

1701-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1200168

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.291.14.1701

http://www.w3.org/2001/XMLSchema#string

10.1001/JAMA.291.14.1775

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P50

Jean Wactawski-Wende

Sylvia Wassertheil-Smoller

Robert D. Langer

P577

2004-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15082697

http://www.w3.org/2001/XMLSchema#string

P921